Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020
| Autor: | Karen Click, Jennifer R. Head, Justin V. Remais, Alexandra K. Heaney, John R. Balmes, John W. Taylor, Kelly Broen, Jon Zelner |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Epidemiology
diagnosis medicine.medical_treatment Disease Infectious and parasitic diseases RC109-216 medicine.disease_cause California Pandemic Ethnicity Medicine risk factors Minority Groups Coronavirus biology Coinfection Arizona Respiratory infection Immunosuppression Infectious Diseases coronavirus disease Synopsis severe acute respiratory syndrome coronavirus 2 Microbiology (medical) medicine.medical_specialty Coccidioidomycosis and COVID-19 Co-Infection United States 2020 coccidioidomycosis coronaviruses respiratory infections Diabetes mellitus Humans Coccidioides viruses Intensive care medicine Pandemics Aged business.industry co-infections SARS-CoV-2 COVID-19 biology.organism_classification medicine.disease United States zoonoses fungi business |
| Zdroj: | Emerging Infectious Diseases Emerging Infectious Diseases, Vol 27, Iss 5, Pp 1266-1273 (2021) |
| ISSN: | 1080-6059 1080-6040 |
| Popis: | We review the interaction between coronavirus disease (COVID-19) and coccidioidomycosis, a respiratory infection caused by inhalation of Coccidioides fungal spores in dust. We examine risk for co-infection among construction and agricultural workers, incarcerated persons, Black and Latino populations, and persons living in high dust areas. We further identify common risk factors for co-infection, including older age, diabetes, immunosuppression, racial or ethnic minority status, and smoking. Because these diseases cause similar symptoms, the COVID-19 pandemic might exacerbate delays in coccidioidomycosis diagnosis, potentially interfering with prompt administration of antifungal therapies. Finally, we examine the clinical implications of co-infection, including severe COVID-19 and reactivation of latent coccidioidomycosis. Physicians should consider coccidioidomycosis as a possible diagnosis when treating patients with respiratory symptoms. Preventive measures such as wearing face masks might mitigate exposure to dust and severe acute respiratory syndrome coronavirus 2, thereby protecting against both infections. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|